{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-030375","form_type":"8-K","ticker":"OSTX","cik":"0001795091","company_name":"OS Therapies Inc","filed_at":"2025-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.747825+00:00","generated_at":"2026-05-23T18:32:02.447635+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Stockholders approve issuance of shares exceeding 20% of outstanding common stock","bullets":["Special meeting held April 9, 2025; proposal passed with 11,587,018 votes in favor (99.3% of votes cast).","Approval covers conversion of 1,775,750 Series A Preferred shares and exercise of warrants from private placement.","Issuance without regard to conversion/exercise limits can dilute existing holders by at least 20%."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-030375","json":"https://secwatch.observer/filing/0001213900-25-030375.json","markdown":"https://secwatch.observer/filing/0001213900-25-030375.md","text":"https://secwatch.observer/filing/0001213900-25-030375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1795091/000121390025030375/0001213900-25-030375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1795091/000121390025030375/ea0237768-8k_ostherapies.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T18:32:02.447635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}